These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3322409)

  • 1. Two-dimensional crystals of enzyme-effector complexes: ribonucleotide reductase at 18-A resolution.
    Ribi HO; Reichard P; Kornberg RD
    Biochemistry; 1987 Dec; 26(24):7974-9. PubMed ID: 3322409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-dimensional crystallization of DNA gyrase B subunit on specifically designed lipid monolayers.
    Lebeau L; Regnier E; Schultz P; Wang JC; Mioskowski C; Oudet P
    FEBS Lett; 1990 Jul; 267(1):38-42. PubMed ID: 2163898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribonucleotide reductase from Escherichia coli. Identification of allosteric effector sites by chromatography on immobilized effectors.
    von Döbeln U
    Biochemistry; 1977 Oct; 16(20):4368-71. PubMed ID: 334242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New crystal forms of the small subunit of ribonucleotide reductase from Escherichia coli.
    Nordlund P; Uhlin U; Westergren C; Joelsen T; Sjöberg BM; Eklund H
    FEBS Lett; 1989 Dec; 258(2):251-4. PubMed ID: 2689216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between the allosteric effector-binding sites in mouse ribonucleotide reductase.
    Reichard P; Eliasson R; Ingemarson R; Thelander L
    J Biol Chem; 2000 Oct; 275(42):33021-6. PubMed ID: 10884394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside 5'-triphosphate analogs as positive and negative effectors of mammalian ribonucleotide reductase.
    Cory JG; Sato A; Bacon PE; Rey DA
    Cancer Biochem Biophys; 1985 Jun; 8(1):23-8. PubMed ID: 3896468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric regulation of Trypanosoma brucei ribonucleotide reductase studied in vitro and in vivo.
    Hofer A; Ekanem JT; Thelander L
    J Biol Chem; 1998 Dec; 273(51):34098-104. PubMed ID: 9852067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization and preliminary crystallographic data of ribonucleotide reductase protein B2 from Escherichia coli.
    Joelson T; Uhlin U; Eklund H; Sjöberg BM; Hahne S; Karlsson M
    J Biol Chem; 1984 Jul; 259(14):9076-7. PubMed ID: 6378906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for allosteric specificity regulation in class Ia ribonucleotide reductase from Escherichia coli.
    Zimanyi CM; Chen PY; Kang G; Funk MA; Drennan CL
    Elife; 2016 Jan; 5():e07141. PubMed ID: 26754917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and preliminary crystallographic studies of R1E, the large subunit of ribonucleotide reductase from Salmonella typhimurium.
    Uppsten M; Färnegårdh M; Jordan A; Ramaswamy S; Uhlin U
    Acta Crystallogr D Biol Crystallogr; 2003 Jun; 59(Pt 6):1081-3. PubMed ID: 12777781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct photoaffinity labeling of ribonucleotide reductase from Escherichia coli using dTTP: characterization of the photoproducts.
    Kierdaszuk B; Eriksson S
    Biochemistry; 1988 Jun; 27(13):4952-6. PubMed ID: 3048394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tyrosyl free radical in ribonucleotide reductase.
    Gräslund A; Sahlin M; Sjöberg BM
    Environ Health Perspect; 1985 Dec; 64():139-49. PubMed ID: 3007085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric Inhibition of Human Ribonucleotide Reductase by dATP Entails the Stabilization of a Hexamer.
    Ando N; Li H; Brignole EJ; Thompson S; McLaughlin MI; Page JE; Asturias FJ; Stubbe J; Drennan CL
    Biochemistry; 2016 Jan; 55(2):373-81. PubMed ID: 26727048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures of eukaryotic ribonucleotide reductase I provide insights into dNTP regulation.
    Xu H; Faber C; Uchiki T; Fairman JW; Racca J; Dealwis C
    Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4022-7. PubMed ID: 16537479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the therapeutic potential of a non-natural nucleotide that inhibits human ribonucleotide reductase.
    Ahmad MF; Wan Q; Jha S; Motea E; Berdis A; Dealwis C
    Mol Cancer Ther; 2012 Oct; 11(10):2077-86. PubMed ID: 22933704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Mechanism of Allosteric Activity Regulation in a Ribonucleotide Reductase with Double ATP Cones.
    Johansson R; Jonna VR; Kumar R; Nayeri N; Lundin D; Sjöberg BM; Hofer A; Logan DT
    Structure; 2016 Jun; 24(6):906-17. PubMed ID: 27133024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytidine 5'-diphosphate reductase activity in phytohemagglutinin stimulated human lymphocytes.
    Tyrsted G; Gamulin V
    Nucleic Acids Res; 1979 Jan; 6(1):305-19. PubMed ID: 424294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribonucleotide reductase from calf thymus. Separation of the enzyme into two nonidentical subunits, proteins M1 and M2.
    Thelander L; Eriksson S; Akerman M
    J Biol Chem; 1980 Aug; 255(15):7426-32. PubMed ID: 6993487
    [No Abstract]   [Full Text] [Related]  

  • 19. A kinetic study on the influence of nucleoside triphosphate effectors on subunit interaction in mouse ribonucleotide reductase.
    Ingemarson R; Thelander L
    Biochemistry; 1996 Jul; 35(26):8603-9. PubMed ID: 8679622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models of the regulation of ribonucleotide reductase and their evaluation in intact mammalian cells.
    Hunting D; Henderson JF
    CRC Crit Rev Biochem; 1982; 13(4):325-48. PubMed ID: 6759037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.